CHEAPEST Covid 19 Vaccine gem .... Low valuation of 49 million --has 3x Phase 3 programs with Data in Q4 / and a Covid 19 Vaccine programm with data coming soon ..has potential to move like INO or NVAX ... Soligenix (SNGX) Marekt Cap $50 Million Price: $1.89 Shares Out 26. 6 M Presentation http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+06.24.20FINAL.pdf Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis https://finance.yahoo.com/news/soligenix-completes-enrollment-pivotal-phase-110000377.html Final top-line results expected Q4 2020 SNGX: Q&A on COVID-19 Vaccine Candidate CiVax™… https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-093900828.html As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share.
Running higher after hour could be a good day tomorrow ...GLTA https://www.nasdaq.com/market-activity/stocks/sngx/after-hours
Nice move in Pre mkt ....market cap of $55 millon is a PURE GIFT for this covid19 vaccine gem https://www.nasdaq.com/market-activity/stocks/sngx/pre-market
Soligenix Inc. Set To Leverage Its Milestone Filled 2019 Toward A Transformational 2020; Chief Scientific Officer Featured In PharmaVOICE Podcast http://news.santafenewsonline.com/s...-officer-featured-in-pharmavoice-podcast.html Soligenix Presentation at 2020 MedInvest Infectious Disease & Immunology Conference